west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "detrusor-sphincter dyssynergia" 1 results
  • Botulinum toxin A injection for neurogenic bladder

    Injection of botulinum toxin A (BTX-A) into the detrusor muscle and urethral sphincter can block the release of acetylcholine from the presynaptic efferent nerve at the neuromuscular junction, inhibit the contraction of the target muscle, improve bladder pressure and urodynamic parameters, reduce the incidence of urinary tract infection and improve quality of life. Currently, BTX-A has been approved by the Food and Drug Administration for the treatment of neurogenic detrusor overactivity and refractory overactive bladder. A recent clinical trial of BTX-A in the treatment of detrusor-sphincter coordination disorders also reported promising therapeutic effects. This article reviews the BTX-A injection therapy for neurogenic detrusor muscle overactivity and detrusor-sphincter dyssynergia induced by upper motor neuron injury, especially cerebral cortex and suprasacral spinal cord injury.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content